Troglitazone has been withdrawn from the U.S. market.
Troglitazone is an antihyperglycemic agent. It helps your body respond better to insulin
and it reduces the amount of sugar produced by your liver. It can help control blood sugar levels.
Troglitazone is used to treat non-insulin-dependent diabetes mellitus (type II diabetes),
along with diet and exercise, and insulin, a sulfonylurea, or metformin (Glucophage) if necessary.
Troglitazone may also be used for purposes other than those listed in this medication
guide.